Unknown PHASE4 INTERVENTIONAL 2-arm NCT00540202

Effectiveness of Oral Quinine and Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria in Ugandan Children (QALE)

Sponsor: Makerere University

Interventions Oral quinine artemether-lumefantrine

Updated 4 times since 2017 Last updated: Oct 4, 2007 Started: Sep 30, 2007 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Uncomplicated Malaria, this trial is ongoing. The trial is conducted by Makerere University and has accumulated 4 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Makerere University
Ministry of Health, Uganda
Uganda Malaria Surveillance Project

Data source: Makerere University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kampala, Uganda